MDMA-Assisted Therapy for PTSD: In conversation with Rick Doblin & Payton Nyquvest
Why is real world evidence important for psychedelic research and how do therapy and psychedelics work together? MAPS founder, Rick…
Why is real world evidence important for psychedelic research and how do therapy and psychedelics work together? MAPS founder, Rick…
Real-world study expands access to MDMA-assisted therapy for patients with PTSD and concurrent disorders and will provide data on a…
Yesterday, MAPS announced significant, positive results for their Phase 3 clinical trial of MDMA-assisted therapy for PTSD – a major…
1 in 11 Canadians will suffer from PTSD in their lifetime. We urgently need new approaches to mental health care…
Cliquez ici pour la version française Significant progress made as Numinus-sponsored PRIME study on psilocybin-assisted psychotherapy for opioid, stimulant and/or…
The study, which is in collaboration with MAPS Public Benefit Corporation (MAPS PBC), subsidiary of the Multidisciplinary Association for Psychedelic…
Cliquez ici pour la version française Trial enters pre-implementation stage having met several key milestones towards expanding access to patients…
Vancouver-based firm Numinus announced yesterday it will collaborate with an arm of a longstanding non-profit association dedicated to the study…
Numinus Wellness Inc. and Multidisciplinary Association for Psychedelic Studies Public Benefit Corporation (MAPS PBC) have teamed up to petition Health Canada for approval…
First-of-its-kind trial in Canada will pave the way for expanded MDMA-assisted treatment to support patients with posttraumatic stress disorder VANCOUVER (December…
Could magic mushrooms treat addiction? Vancouver based company Numinus has announced a new clinical trial of psilocybin-assisted psychotherapy to treat…
Vancouver-based Numinus Wellness Inc. has announced a 30-person clinical trial to establish the best practices for treating substance use disorders…
Magic Mushrooms, now legal in Oregon. have shown promise in treatment of addiction and depression. The question is — will the…
Open-label clinical trial will evaluate and refine best practices for the delivery of psilocybin-assisted psychotherapy for participants with tobacco, stimulant,…